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a b s t r a c t
We have recently shown that overnight exposure of INS-1E insulinoma cells to palmitate in the presence
of high glucose causes defects in both mitochondrial energy metabolism and glucose-stimulated insulin
secretion (GSIS). Here we report experiments designed to test the involvement of mitochondrial
uncoupling protein-2 (UCP2) in these glucolipotoxic effects. Measuring real-time oxygen consumption
in siRNA-transfected INS-1E cells, we show that deleterious effects of palmitate on the glucose sensitivity
of mitochondrial respiration and on the coupling efﬁciency of oxidative phosphorylation are indepen-
dent of UCP2. Consistently, palmitate impairs GSIS to the same extent in cells with and without UCP2.
Furthermore, we knocked down UCP2 in spheroid INS-1E cell clusters (pseudoislets) to test whether or
not UCP2 regulates insulin secretion during prolonged glucose exposure. We demonstrate that there are
no differences in temporal GSIS kinetics between perifused pseudoislets with and without UCP2. We
conclude that UCP2 is not involved in palmitate-induced impairment of GSIS in INS-1E insulinoma cells
and is not needed for the ampliﬁcation of insulin release. These conclusions inform ongoing debate on
the disputed biochemical and physiological functions of the beta cell UCP2.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Pancreatic beta cells secrete insulin in response to an increase
in the blood glucose level [1]. Mitochondria play an important role
in this glucose-stimulated insulin secretion (GSIS) as they generate
signals during oxidative glucose catabolism that trigger and
amplify insulin release [2]. In the canonical model of GSIS, glucose
breakdown causes an increase in the cytoplasmic ATP/ADP ratio,
which leads, sequentially, to the inhibition of KATP channels,
depolarisation of the plasma membrane potential, opening of
voltage-gated calcium channels, calcium inﬂux, and the exocytosis
of insulin-containing granules [1]. Whilst this triggering sequence
of events accounts for GSIS in the short term, less well understood
amplifying mechanisms are necessary to sustain insulin release for
a prolonged period of time [3]. The glucose sensitivity of the ATP/
ADP ratio is a characteristic of pancreatic beta cells that reﬂects the
extraordinary bioenergetics of these cells: whilst in most cell types
the ATP/ADP poise is controlled exclusively by ATP turnover, in
beta cells this ratio is largely governed by glucose oxidation, i.e.
ATP supply [4]. This unusual control structure of energy metabo-
lism allows regulation of the ATP/ADP ratio – and hence insulin
secretion – by the coupling efﬁciency of oxidative phosphorylation.
Pancreatic beta cells contain a mitochondrial uncoupling pro-
tein (UCP2, [5]) that, in analogy with the archetypal uncoupling
protein UCP1 [6], is believed to dissipate the mitochondrial
protonmotive force as heat and thus uncouple oxidative phos-
phorylation [7]. Recent work on proteoliposomes has revealed,
however, that reconstituted UCP2 protein exhibits speciﬁc sub-
strate exchange activity, which suggests UCP2 exports carbon
skeletons from the mitochondrial matrix [8]. Given the unresolved
molecular function of UCP2, it is perhaps not surprising that the
protein's physiological role in beta cells has not yet been estab-
lished conclusively either. Depending on their genetic background,
global Ucp2 knockout mice exhibit either improved glucose
tolerance and GSIS [5,9] or unaltered glucose tolerance [10] and
impaired GSIS [9]. Beta-cell-speciﬁc ablation of UCP2 leads to
glucose-intolerant mice whose pancreatic islets, however, exhibit
higher GSIS than their wild type counterparts [11]. These discre-
pant observations have led to different functional models that
predict a pathological role for UCP2 in beta cell failure and
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consequent development of Type 2 diabetes on the one hand [12],
and a physiological role in protecting cells against oxidative stress
on the other [13]. Biochemical studies with INS-1E insulinoma
cells support the possibility that, by dampening the generation of
glucose-induced mitochondrial reactive oxygen species, UCP2
acutely attenuates GSIS and, in the long term, prevents oxidative
stress [14,15]. Informed by effects on mitochondrial coupling
efﬁciency and GSIS in INS-1E cells, we previously proposed a role
for UCP2 in regulating the beta cells' physiological response to
ﬂuctuations in nutrient supply [16]. More speciﬁcally, we hypothe-
sised that by partially uncoupling oxidative phospho-
rylation, UCP2 allows turnover of the tricarboxylic acid cycle
beyond the control of the ATP/ADP ratio. Such uncontrolled turn-
over would ensure production of mitochondrial GSIS ampliﬁcation
signals that are necessary to sustain insulin secretion when
nutrient levels, and hence the ATP/ADP ratio, are high [16].
Recently, we have shown that palmitate impairs GSIS in INS-1E
cells when administered overnight at high glucose [17]. This
glucolipotoxic phenotype coincides with mitochondrial defects:
palmitate decreases the glucose sensitivity of mitochondrial
respiration and also lowers coupling efﬁciency of oxidative phos-
phorylation [17]. Palmitoleate, i.e., palmitate's monounsaturated
counterpart, does not exert deleterious effects on GSIS and
mitochondrial energy transduction, but does not protect against
palmitate-provoked damage either [17]. Palmitate-induced defects
are indeed reminiscent of how UCP2 affects the mitochondrial
bioenergetics and GSIS of INS-1E cells [14,15]. In line with mouse
and islet studies reported by others [18,19], it is thus conceivable
that UCP2 mediates the mitochondrial respiratory dysfunction and
associated GSIS impairment caused by palmitate in INS-1E cells
[17]. This hypothesis has not yet been tested in insulinoma cells.
In this paper we report studies that were designed to test
(i) whether or not UCP2 mediates the detrimental effects of
palmitate on oxidative phosphorylation and GSIS in INS-1E cells
and (ii) if UCP2 is needed to sustain insulin secretion during
prolonged glucose exposure. Via an RNAi approach we show that
palmitate disturbs mitochondrial respiration and GSIS in a similar
way, qualitatively and quantitatively, in INS-1E cells with and with-
out UCP2. Effects of palmitate on the bioenergetics of INS-1E
cells7UCP2 are consistent with the lack of UCP2 inﬂuence on the
GSIS phenotype. Furthermore, we reveal that spheroid INS-1E cell
clusters (pseudoislets [20,21]) exhibit temporal GSIS kinetics that are
also independent of UCP2. We conclude that UCP2 is not responsible
for palmitate-induced GSIS impairment in INS-1E insulinoma cells
and is not required for the ampliﬁcation of insulin release.
2. Materials and methods
2.1. Tissue culture
INS-1E cells were donated by Prof. Noel Morgan (University of
Exeter Medical School) and maintained according to [22] in RPMI-
1640 growth medium that contained 11 mM glucose and was
supplemented with 5% (v/v) foetal bovine serum, 10 mM Hepes
(pH 7.4), 1 mM sodium pyruvate, 50 U/mL penicillin, 50 mg/mL
streptomycin, 500 mM β-mercaptoethanol and 2 mM glutaMAX
(Catalogue #35050-061, Life Technologies). To facilitate the for-
mation of pseudoislets, 3106 INS-1E cells were added in 7.5 mL
RPMI to 75 cm2 suspension culture ﬂasks (Greiner bio-one
#658195) that were coated with 1% (w/v) gelatin [21].
2.2. UCP2 knockdown and detection
UCP2 protein was knocked down in INS-1E cells via RNAi as
described before [23] applying 200 nM scrambled or Ucp2-
targeted siRNA oligonucleotides (both from Ambion, Huntington,
UK) and 1.67 mg/mL Lipofectamine™ (Invitrogen, Paisley, UK). To
generate UCP2-depleted pseudoislets, INS-1E cells were trans-
fected immediately after adding them to gelatin-coated ﬂasks
using the same transfection agent and siRNA speciﬁcations as
used for cells. After 24 h, pseudoislets were harvested by 2-min
centrifugation at 200g, resuspended in fresh growth medium and
then cultured for another 4 days before insulin secretion was
measured. UCP2 protein depletion in pseudoislets was conﬁrmed
by Western blotting analysis as described before [24]. To prepare
samples for this analysis, pseudoislets were spun down by 1-min
centrifugation at 1000g and then resuspended in 40 mL ice-cold
lysis buffer containing 50 mM Tris–HCl (pH 8.0), 1% (v/v) Nonidet
P40, 0.25% (w/v) sodium deoxycholate, 0.1% (v/v) SDS, 150 mM
NaCl, 1 mM EDTA and 500x diluted protease inhibitor (#P8340,
Sigma-Aldrich). After vigorous shaking for 20 min at 4 1C, non-
solubilised material was pelleted by 15-min centrifugation at
14,000g and 4 1C. Protein levels of the supernatants were quanti-
ﬁed by bicinchoninic acid assay (Thermo Scientiﬁc 23227) and
50 mg of protein was precipitated with ice-cold acetone. After 1-h
incubation at 20 1C, protein was pelleted and resuspended in
loading buffer appropriate for polyacrylamide gel electrophoresis
and subsequent Western blotting analysis [24].
2.3. Fatty acid exposure
The non-esteriﬁed fatty acids (NEFAs) palmitate and palmitole-
ate were added in conjugation to fatty-acid-free bovine serum
albumin (BSA, Sigma-Aldrich A7030) as described in [17]. Trans-
fected and non-transfected INS-1E cells were exposed to NEFAs as
described in [24]. Control cells were exposed to BSA alone.
2.4. Bioenergetics
Mitochondrial oxygen consumption was measured in INS-1E
cells using a Seahorse XF24 extracellular ﬂux analyser as described
before [17]. Glucose sensitivity of mitochondrial respiration was
calculated as glucose-stimulated oxygen consumption normalised
to basal respiratory activity, whilst the coupling efﬁciency of
oxidative phosphorylation was deﬁned as the oligomycin-
sensitive part of glucose-stimulated mitochondrial respiration
[23]. Absolute respiratory activities were determined by norma-
lising oxygen uptake rates to INS-1E cell number. Cell densities
were determined by ﬂuorescent DAPI-staining as described in [24].
2.5. Static GSIS
Insulin secretion was measured in INS-1E cell monolayers as
described in [17]. Measuring static insulin secretion in INS-1E
pseudoislets, the monolayer protocol was adapted to deal with the
relatively high mobility of spheroid cell clusters. Pseudoislets were
‘hand-picked’ under a stereotactic microscope using a P20 pipettor
and were transferred to a V-bottomed 96-well plate (Greiner bio-
one #651101) dispending 15 cell clusters per well in a total volume
of 10 mL growth medium. Pseudoislets were starved from glucose
by adding 90 mL glucose-free RPMI (Sigma # R1383) supplemented
with 1% (v/v) foetal bovine serum, 10 mM Hepes (pH 7.4), 50 U/mL
penicillin, 50 mg/mL streptomycin, 500 mM β-mercaptoethanol
and 2 mM glutamine. Pseudoislets were washed once and then
incubated in this starvation medium for 2 h at 37 1C in a humidi-
ﬁed 5% CO2 atmosphere. Subsequently, cell clusters were washed
into glucose-free Krebs–Ringer-Hepes buffer (KRH) comprising
135 mM NaCl, 3.6 mM KCl, 10 mM Hepes (pH 7.4), 0.5 mM MgCl2,
0.75 mM CaCl2, 0.5 mM NaH2PO4, 2 mM glutamine and 0.1% (w/v)
BSA, and then incubated in this buffer for 30 min at 37 1C under
air. At this point, 80 mL supernatant was removed for deter-
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mination of basal insulin secretion. This volume was replaced
immediately by KRH containing 28 mM glucose and clusters were
incubated for another 30 min at 37 1C under air. At this point,
80 mL supernatant was taken for determination of glucose-
stimulated insulin secretion. All collected samples were spun for
5 min at 14,000 g (4 1C) to pellet carried-over cells, and super-
natants were stored at 80 1C. Insulin was assayed by ELISA
(Mercodia, Uppsala, Sweden) using mouse insulin as a standard.
To measure DNA content, pseudoislets were resuspended in a total
volume of 250 mL lysis buffer (see UCP2 detection) and shaken
vigorously for 5 min at 4 1C. Solubilised samples were stored at –
80 1C until DNA level was determined with the Quant-iT™ Pico-
Greens dsDNA Assay Kit (Life technologies #P7589) according to
the manufacturer's instructions using the high range standard
curve. Insulin secretion by INS-1E pseudoislets was normalised to
DNA content.
2.6. Temporal insulin secretion kinetics
Pseudoislets were harvested from a single 75 cm2 ﬂask by 2-min
centrifugation at 200 g and were resuspended in 220 mL KRH with
200 mM glucose. Based on [21], 190 mL pseudoislet suspension was
pipetted into a Swinnex 13 ﬁlter holder (Millipore) ﬁtted with a
0.1 mm nylon mesh (Plastok associates). KRH with 200 mM glucose
was pumped continuously through 3 pseudoislet-containing parallel
chambers at a ﬂow rate of 0.5 mL min1 using a peristaltic pump
(Gilson Minipuls 3, peristaltic tubing orange yellow, ID 0.51 mm) and
silicone tubing (Corning medical grade, ID: 1.98 mm, OD: 3.18 mm).
The perifusion setup was placed in a bench top incubator (Stuart
SI60D) to maintain a constant temperature of 37 1C. Following a 30-
min wash, perifusate was collected in 2-min intervals for 50 min.
Glucose and KCl levels of the perifusion buffer were altered as
described in the legends of Figs. 4 and 6. Perifusate fractions were
stored on ice and carried-over cells were spun down after the
experiment by 1-min centrifugation at 1000g. Supernatants were
either stored at 80 1C or assayed directly for insulin as above.
2.7. Statistics
Differences between means were tested for statistical signiﬁ-
cance by ANOVA as speciﬁed in the ﬁgure legends using GraphPad
Prism Version 6.0 for Mac OS X (GraphPad software, San Diego,
CA, USA).
3. Results
3.1. UCP2 does not mediate NEFA effects on GSIS
Transfection of INS-1E cells with Ucp2-targeted siRNA oligonu-
cleotides results in UCP2 depletion to a level below the detection
limit of our Western blotting assay [24]. Since cells transfected
with scrambled siRNA contain the same UCP2 protein level as non-
transfected cells [24], and since UCP2 knockdown is not affected
by NEFA exposure [24], we deemed this RNAi approach suitable for
exploring the involvement of UCP2 in palmitate-induced GSIS
impairment. Non-transfected INS-1E cells grown in serum-
containing medium and then starved from glucose 2 h before
the GSIS assay, increase their insulin secretion rate almost 6-fold
when subjected to 28 mM glucose (Fig. 1). GSIS in INS-1E cells
transfected with scrambled siRNA is less pronounced, as insulin
secretion is increased only just over 2-fold at 28 mM glucose in
these cells. Not statistically signiﬁcant but in line with our
previous data [14,15], cells transfected with Ucp2-targeted siRNA
exhibit higher GSIS than their scrambled-siRNA-transfected
equivalents when grown in serum-containing medium. GSIS is
not affected signiﬁcantly by serum deprivation (Fig. 1, BSA),
neither in non-transfected nor in transfected cells, although the
UCP2 phenotype appears to have been annulled by small non-
signiﬁcant effects. In agreement with our recent results [17],
overnight palmitate exposure at 11 mM glucose almost completely
abolishes GSIS in non-transfected cells (Fig. 1). Palmitate also
dampens GSIS in transfected cells but the effects are relatively
modest and not statistically signiﬁcant (P¼0.99 and 0.33 for cells
transfected with scrambled and Ucp2-targeted siRNA, respec-
tively), likely because they emerge against a background of
transfection-provoked stress (Fig. 1). Palmitate lowers GSIS to a
similar level in transfected and non-transfected cells and, impor-
tantly, UCP2 knockdown does not alter this GSIS impairment
signiﬁcantly. Unlike palmitate, the monounsaturated palmitoleate
does not cause any GSIS defects (Fig. 1). Instead, palmitoleate
potentiates GSIS in transfected and non-transfected cells, although
not to a statistically signiﬁcant extent (P¼0.71, 0.13 and 0.81 for
non-transfected, scrambled-transfected and Ucp2-targeted cells,
respectively). This stimulatory effect is reminiscent of the signiﬁ-
cant GSIS increase observed in INS-1E cells exposed to palmitole-
tate at 4 mM glucose [17]. Importantly, the apparent GSIS
potentiation does not require UCP2 (Fig. 1). The deleterious
palmitate effect on GSIS is not signiﬁcantly ameliorated by
palmitoleate in cells7UCP2 (Fig. 1). UCP2 knockdown [14] and
NEFA exposure [26] may lead to changes in insulin content that
could account, in principle, for the observed GSIS phenotypes
(Fig. 1). Irrespective of the exact mechanism, our data demonstrate
that UCP2 does not inﬂuence the NEFA effects on GSIS.
3.2. UCP2 does not account for NEFA effects on oxidative
phosphorylation
We have shown before that mitochondrial oxygen uptake in
INS-1E cells cultured at 11 mM glucose, and then incubated in the
absence of glucose 30 min before the respiratory assay, typically
increases about 2-fold when cells are subjected to 11–28 mM
glucose [17]. We have also shown that the mitochondrial respira-
tory sensitivity to glucose of transfected cells is considerably
lower: ‘scrambled’ control cells starved from glucose for 2 h before
the assay increase their oxygen uptake rate by a mere 1.3-fold
when 30 mM glucose is added [15], whilst cells lacking UCP2
Fig. 1. Effect of NEFAs on GSIS in INS-1E cells7UCP2. GSIS was calculated as the
fold increase in insulin secretion exhibited by glucose-starved cells in response to
28 mM glucose. GSIS was measured in non-transfected cells (black bars) and in
cells transfected with scrambled or Ucp2-targeted siRNA (white and grey bars,
respectively). Before the GSIS assay, cells were incubated in fully supplemented
medium (RPMI), or were exposed for 24 h in serum-deprived medium to BSA-
conjugated NEFAs (PA¼palmitate, POA¼palmitoleate, PAþPOA¼palmitate and
palmitoleate) or to BSA alone. Bars represent means7SEM of 5 separate experi-
ments in which each condition was measured 3 times. Statistical signiﬁcance of
mean differences was tested by 2-way ANOVA with Dunnett's multiple compar-
isons post-hoc analysis: A differs from a (Po0.01).
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respond a little more strongly and show a 1.7-fold respiratory
increase [15]. Consistently, in the experiments reported here,
serum-deprived INS-1E cells transfected with scrambled siRNA
increase their mitochondrial respiratory activity 1.5-fold in
response to 28 mM glucose (Fig. 2A). This glucose-sensitivity is a
little higher in UCP2-depleted cells, which increase mitochondrial
respiratory activity approximately 1.7-fold (Fig. 2A). Palmitate-
exposed cells only increase mitochondrial respiration about 1.2-
fold when glucose is added (Fig. 2A), which is a signiﬁcantly lower
response than that of BSA control cells. The response by palmitate-
exposed cells is of the same magnitude as we have seen before
[17] and, importantly, does not depend on UCP2. Palmitoleate,
administered alone or with palmitate, does not signiﬁcantly
change the glucose-sensitivity of mitochondrial respiration in cells
with or without UCP2 (Fig. 2A).
Compared to our previous experiments [17], NEFA effects on
coupling efﬁciency of oxidative phosphorylation are relatively
small, and they are indeed statistically not signiﬁcant (Fig. 2B).
Consistent with previous results [15], however, UCP2 knockdown
tends to increase coupling efﬁciency in serum-deprived BSA
control cells subjected to high glucose (Fig. 2B). Coupling efﬁciency
of scrambled-transfected cells (Fig. 2B, BSA) is similar to the
efﬁciency of non-transfected cells [17] but is relatively insensitive
to palmitate (Fig. 2B, PA). In UCP2-depleted cells, palmitate tends
to dampen coupling efﬁciency (Fig. 2B, P¼0.16). Palmitoleate,
added alone or with palmitate, does not change coupling efﬁ-
ciency irrespective of UCP2 (Fig. 2B).
In line with our recent observations [17] overnight NEFA
exposure at 11 mM glucose does not affect the absolute respiratory
activity of INS-1E cells incubated without glucose (Fig. 3A). The
lack of signiﬁcant NEFA effect on this basal respiration is apparent
in INS-1E cells that either contain or lack UCP2 (Fig. 3A). UCP2
depletion lowers the absolute basal respiratory rate in BSA control
and palmitate-exposed cells, but these minor decreases are statis-
tically insigniﬁcant (Fig. 3A). UCP2 knockdown does not affect
absolute mitochondrial oxygen consumption stimulated by 28 mM
glucose (Fig. 3B). Unlike non-transfected INS-1E cells [17], glucose-
stimulated respiration is relatively insensitive to palmitate in cells
transfected with scrambled siRNA (Fig. 3B) but, interestingly, UCP2
depletion augments palmitate sensitivity signiﬁcantly (Fig. 3B).
Palmitoleate lowers absolute glucose-stimulated respiration some-
what in scrambled-transfected cells, but this effect is only statis-
tically signiﬁcant when palmitoleate is added together with
palmitate (Fig. 3B). In Ucp2-transfected cells, absolute glucose-
stimulated respiration is insensitive to palmitoleate (Fig. 3B). Cells
lacking UCP2 thus exhibit marginally higher glucose-stimulated
mitochondrial respiratory rates after palmitoleate exposure
(7palmitate) than cells with UCP2 (Fig. 3B).
The trends we saw for glucose-stimulated respiration (Fig. 3B)
are echoed by oligomycin-sensitive respiration, i.e., by the absolute
mitochondrial oxygen consumption that is used to produce ATP
(Fig. 3C). A marginal respiratory rate-lowering effect of palmitate
in scrambled-transfected cells is signiﬁcantly exacerbated by UCP2
knockdown, and oxygen uptake after palmitoleate exposure
(7palmitate) tends to be a little higher in cells without than with
UCP2 (Fig. 3C). Notably, BSA control cells exhibit comparably high
absolute oligomycin-sensitive oxygen consumption after UCP2
knockdown (Fig. 3C). Palmitate also tends to decrease the
oligomycin-resistant respiration, i.e., the absolute oxygen uptake
that is associated with proton leak across the mitochondrial inner
membrane in cells7UCP2 (Fig. 3D, P¼0.87 and 0.78, respectively).
Although not signiﬁcant, these relatively small effects on proton
leak are worth notice as they were not observed in non-
transfected cells [17] and help to explain the relatively modest
effect of palmitate on coupling efﬁciency of transfected cells
(Fig. 2B): the dampening palmitate effect on respiration linked to
ATP synthesis (Fig. 3C) that lowers coupling efﬁciency, is (partly)
compensated by a concomitant lowering effect on proton leak
(Fig. 3D). As the case for basal respiration (Fig. 3A), UCP2 knock-
down lowers proton leak activity in BSA control and palmitate-
exposed cells a little but not to a signiﬁcant extent (Fig. 3D). Like
palmitate, palmitoleate appears to lower oligomycin-insensitive
respiration in cells with UCP2 (P¼0.56 and 0.227palmitate,
respectively) and without UCP2 (P¼0.96 and 0.807palmitate,
respectively) although variation between experiments is high
(Fig. 3D).
3.3. UCP2 is not necessary for GSIS ampliﬁcation
GSIS by pancreatic beta cells is a biphasic process: an initial
short-term glucose-induced increase in insulin secretion is
accounted for by the canonical GSIS triggering mechanism, whilst
prolonged insulin release requires engagement of GSIS ampliﬁca-
tion pathways [3]. To test the notion that UCP2 may allow
generation of mitochondria-derived GSIS ampliﬁcation signals
[2,16], we measured the temporal kinetics of insulin release by
spheroid INS-1E cell clusters. The time-resolved data in Fig. 4
show that these INS-1E pseudoislets roughly triple their insulin
secretion rate when subjected to glucose. Stimulated secretion is
sustained for at least 30 min, which conﬁrms that GSIS amplifying
pathways are operational and agrees with INS-1E pseudoislet
behaviour reported by others [21,22]. Similarly, the relatively
sharp transient KCl-induced increase in insulin secretion is
Fig. 2. NEFA effects on oxidative phosphorylation in INS-1E cells7UCP2. The
sensitivity of mitochondrial respiration to 28 mM glucose (panel A) and coupling
efﬁciency of glucose-stimulated oxidative phosphorylation (panel B) were deter-
mined in cells transfected with scrambled or Ucp2-targeted siRNA (white and grey
bars, respectively). Before the respiratory assay, cells were incubated for 24 h in
serum-deprived medium and exposed to BSA-conjugated NEFAs (PA¼palmitate,
POA¼palmitoleate, PAþPOA¼palmitate and palmitoleate) or to BSA alone. Bars
represent means7SEM of 4–5 separate experiments in which each condition was
measured 3–4 times. Statistical signiﬁcance of mean differences was tested by
2-way ANOVA with Sidak's multiple comparisons posthoc analysis: A differs from a
(Po0.01) and B differs from b (Po0.001).
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consistent with published results [22]. Like dispersed INS-1E cells
[25], pseudoislets express a signiﬁcant level of UCP2 protein
(Fig. 5A). Transfection with Ucp2-targeted siRNA lowers the UCP2
level by almost 70%, whilst scrambled-transfected pseudoislets
contain as much UCP2 protein as their non-transfected counter-
parts (Fig. 5A). Although variation is rather large, static insulin
secretion experiments show that GSIS tends to be more pro-
nounced in UCP2-depleted than in control pseudoislets (Fig. 5B,
P¼0.73), an observation that is consistent with our INS-1E cell
ﬁndings (Fig. 1A, [14,15]). Pseudoislets that were transfected with
scrambled siRNA exhibit temporal GSIS kinetics (Fig. 6) that are
similar to those observed in non-transfected cell clusters (Fig. 4),
and the insulin secretory response to KCl is near-identical in these
systems as well. Importantly, UCP2 depletion does not change the
time-resolved insulin secretion proﬁle to a statistically signiﬁcant
extent (Fig. 6), strongly suggesting that UCP2 is not needed to
sustain GSIS. Similarly, deleterious palmitate effects on the insulin
secretory proﬁle of pseudoislets are not affected by UCP2 deple-
tion (data not shown).
4. Discussion
The involvement of UCP2 in pancreatic beta cell glucolipotoxi-
city remains controversial [26], largely because neither the bio-
chemical nor the physiological function of this mitochondrial
protein has been established conclusively at present. The sug-
gested pathological model of UCP2 in development of Type
2 diabetes [12] predicts UCP2 mediates deleterious effects of fatty
acids on beta cells, whilst the more recently proposed physiolo-
gical role of UCP2 in protecting beta cells against oxidative stress
[13] predicts UCP2 ameliorates such effects instead. The data
reported here do not support either prediction. We demonstrate
that UCP2 knockdown does not signiﬁcantly affect palmitate-
induced GSIS impairment in INS-1E cells (Fig. 1). This lack of
UCP2 phenotype is echoed by the relative insensitivity of
palmitate-induced mitochondrial respiratory defects to UCP2
depletion (Figs. 2 and 3). Moreover, we reveal that UCP2 activity
Fig. 3. NEFA effects on absolute respiration in INS-1E cells7UCP2. Oxygen uptake was determined and normalised to cell number in INS-1E cells transfected with scrambled
or Ucp2-targeted siRNA (white and grey bars, respectively). Before the respiratory assay, cells were incubated for 24 h in serum-deprived medium and exposed to BSA-
conjugated NEFAs (PA¼palmitate, POA¼palmitoleate, PAþPOA¼palmitate and palmitoleate) or to BSA alone. During the respiratory assay, cells were incubated728 mM
glucose (panels B and A, respectively) and glucose-stimulated oxygen uptake was inhibited with 5 mg/mL oligomycin to distinguish respiration coupled to ATP synthesis from
respiration associated with proton leak (panels C and D, respectively). Bars represent means7SEM of 4–5 separate respiratory assays and cell densities to normalise
respiration were determined from DAPI-ﬂuorescence (cf. [24]) in 3–4 parallel experiments. Each condition was probed 3–4 times in all experiments. Statistical signiﬁcance of
mean differences was tested by 2-way ANOVA with Sidak's multiple comparisons posthoc analysis: A differs from a (Po0.05 and Po0.0001 in panels B and C, respectively)
and B differs from b (Po0.001).
Fig. 4. Temporal kinetics of insulin secretion. Time-resolved insulin secretion by
INS-1E pseudoislets was measured as described in “Section 2.6”. Pseudoislets were
perifused with buffer containing 200 mM glucose and then subjected, sequentially,
to 30 mM glucose (G30) and 50 mM KCl at the times indicated by dotted lines.
Insulin levels were determined in perifusate fractions taken at 2-min intervals, and
insulin secretion was normalised to the average secretory rate observed before
glucose addition. Data represent means7SEM of 7 independent experiments.
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is not needed to sustain insulin secretion by INS-1E pseudoislets
for a prolonged period of time (Fig. 6).
4.1. Molecular function of UCP2
Because of considerable sequence homology with the relatively
well characterised UCP1, UCP2 was labelled a novel uncoupling
protein upon its discovery [27]. However, evidence to conﬁrm that
UCP2 indeed does what its label suggests, remains scarce. Direct
support for the assertion that UCP2 partially dissipates the
mitochondrial protonmotive force, and thus uncouples oxidative
phosphorylation, has only been obtained from studies with
reconstituted UCP2 protein or isolated mitochondria [7], i.e.,
experimental systems of limited physiological relevance. Vozza
et al. recently revealed that UCP2 catalyses the proton-assisted
exchange – across liposome membranes – of phosphate for either
malate, oxaloacetate or aspartate [8]. This speciﬁc molecular
exchange suggests UCP2 exports carbon from the mitochondrial
matrix [8], which may attenuate glucose breakdown whilst sti-
mulating glutaminolysis [8], and may thus offer a glucose-sparing
metabolic switch [28]. This suggestion agrees with UCP2 effects on
glutamine catabolism in macrophages [29] and on glucose/fatty
acid oxidation in ﬁbroblasts [30]. The possible fate of UCP2-
exported carbon in pancreatic beta cells is less clear, although it
is conceivable that UCP2 participates in incompletely understood
substrate cycles necessary for glucose catabolism in these cells
[31]. A prediction of the carbon export model is that UCP2 limits
glucose oxidation [8], but experiments with mouse islets [32] and
INS-1E cells [14,15] demonstrate that UCP2 contributes to mito-
chondrial respiration instead. Consistently, UCP2 knockdown
tends to lower basal oxygen uptake (Fig. 3A) and oxygen uptake
linked to proton leak (Fig. 3D) in our experiments with serum-
deprived BSA control cells grown at high glucose without NEFAs.
This contribution of UCP2 to glucose-fuelled respiration is readily
explained by uncoupling, but clearer insight in beta cell bioener-
getics is needed before other models, perhaps involving carbon
substrate cycles, can be excluded.
4.2. UCP2 involvement in glucolipotoxicity
We show here that UCP2 is not involved in palmitate-induced
GSIS impairment in INS-1E cells (Fig. 1) and the associated damage
to mitochondrial energy metabolism (Fig. 2). These ﬁndings are
consistent with our observation that palmitate/palmitoleate expo-
sure does not alter UCP2 protein in INS-1E cells [24], but are
discrepant with mouse and islet studies reported by others [18,19].
This discrepancy may reﬂect the limited physiological relevance of
INS-1E cells, but as asserted before [15], the relative complexity of
Fig. 5. Effect of UCP2 knockdown on static GSIS by INS-1E pseudoislets. (Panel A) Part of a typical Western blot showing equal presence of UCP2 protein in non-transfected
(con, black bar) and scrambled-transfected (scr, white bar) pseudoislets. The bottom band of the shown doublets represents UCP2 as is demonstrated by its relatively low
intensity in pseudoislets transfected with Ucp2-targeted siRNA (ucp2, grey bar) and its position relative to human recombinant UCP2 protein (rUCP2). UCP2 protein levels
were compared between systems as described in detail elsewhere [24] and were normalised to the level detected in non-transfected cells. Bars represent means7SEM of
4 separate pseudoislet preparations. Statistical signiﬁcance of mean differences was tested by 1-way ANOVA with Dunnett's multiple comparisons posthoc analysis: ***
differs from non-transfected control cells (Po0.001). (Panel B) Normalised insulin secretory response of glucose-starved pseudoislets to 28 mM glucose measured in a static
GSIS assay (see Section 2.5). Black, white and grey bars represent means7SEM of 3–4 separate experiments with non-transfected, scrambled-transfected and Ucp2-
transfected pseudoislets, respectively. Each condition was measured 3 times in all experiments and 2-way ANOVA revealed that differences between means are not
statistically signiﬁcant.
Fig. 6. UCP2 knockdown does not affect the temporal kinetics of insulin secretion.
Time-resolved insulin secretion was measured as described in “Section 2.6” using
INS-1E pseudoislets transfected with scrambled or Ucp2-targeted siRNA (white and
grey symbols, respectively). Pseudoislets were perifused with buffer containing
200 mM glucose and then subjected, sequentially, to 30 mM glucose (G30) and
50 mM KCl at the times indicated by dotted lines. Insulin levels were determined in
perifusate fractions taken at 2-min intervals, and insulin secretion was normalised
to the average secretory rate observed before glucose addition. Data represent
means7SEM of 6 (scrambled-transfected) or 8 (Ucp2-transfected) independent
experiments. ANOVA for repeated measurements reveals differences between
means are not statistically signiﬁcant.
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mouse models partly accounts for ongoing debate surrounding the
physiological role of UCP2 and its engagement with glucolipotoxi-
city. Cell models allow UCP2 effects to be probed relatively acutely
and under comparably well controlled conditions. Notwithstand-
ing, cells too are sensitive to small differences in experimental
design. Coupling efﬁciency of oxidative phosphorylation is e.g.
lowered by palmitate in untreated INS-1E cells [17], but not altered
signiﬁcantly in siRNA-transfected cells (Fig. 2B). Also, the protective
tendency of palmitoleate against palmitate-induced GSIS impair-
ment (Fig. 1) was not seen before [17].
Mirroring the lack of UCP2 effect on palmitate-induced oxida-
tive phosphorylation defects (Figs. 2 and 3), UCP2 does also not
affect the palmitate-provoked formation of mitochondrial super-
oxide that correlates with INS-1E cell loss [24]. Instead, UCP2
modulates palmitoleate protection against palmitate-related oxi-
dative damage [24]. Monounsaturated NEFAs protect insulinoma
cells both against saturated fatty acids and against stress incurred
upon cytokine exposure or serum-deprivation [33]. Consistently,
UCP2 knockdown protects against the moderate loss of serum-
deprived INS-1E cells grown at high glucose [24]. Interestingly in
this respect, lipofectamine-mediated transfection of INS-1E pseu-
doislets with scrambled siRNA lowers the absolute rate of insulin
secretion, most likely owing to loss of cells – UCP2 knockdown
prevents this lipofectamine-induced loss of cells (not shown).
5. Conclusion
Our ﬁndings disprove the hypotheses we set out to test and we
conclude that UCP2 does not mediate palmitate-induced impair-
ment of mitochondrial energy transduction and GSIS in INS-1E
cells, and is not necessary for GSIS ampliﬁcation. Importantly,
these ‘negative’ results inform ongoing debate on the enigmatic
functions of the beta cell UCP2.
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